The “Rerouting Minds” webpage comprises information about LSD’s clinical history dating back to the 1930s, about how ...

Leaders of the D.S.M., the world’s most influential psychiatric manual, have been split for more than five years over whether ...

When it comes to the market for cognitive and energy support, experts note that the market’s sustained growth speaks to the ...

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with effective oral delivery, today announced that enrollment ...

What investors want to see is Tonix Pharmaceuticals ( TNXP) move away from a cash-burning R&D company and into having more of a recurring revenue base from its current approved drugs. As of now, the ...

Neurotech says US regulatory changes could spur its efforts to develop medicinal cannabis treatments for childhood ...

FIVE everyday household items could be putting pets in danger – from a “lucky” penny on the floor to a soothing-smelling ...

New clinical guidelines recognise the emotional burden of diabetes as a critical component of care, with recommendations for ...

Dr. Hans Eriksson, Chief Medical Officer, presented clinical findings from the OLIVE Phase 2b trial, which evaluated BH-200 ...

AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable and convenient ...

Detailed price information for Scienture Holdings Inc (SCNX-Q) from The Globe and Mail including charting and trades.